9999999997-18-004003.txt : 20180402 9999999997-18-004003.hdr.sgml : 20180402 20180402093304 ACCESSION NUMBER: 9999999997-18-004003 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20180402 DATE AS OF CHANGE: 20180402 ACTION DATE: 20180402 RECEIVED DATE: 20180402 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Regulus Therapeutics Inc. CENTRAL INDEX KEY: 0001505512 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264738379 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-35670 FILM NUMBER: 18727436 BUSINESS ADDRESS: STREET 1: 10614 SCIENCE CENTER DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-202-6300 MAIL ADDRESS: STREET 1: 10614 SCIENCE CENTER DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 CT ORDER 1 filename1.pdf begin 644 filename1.pdf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